Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
Clinical trial NCT00458679 · COMPLETED
Trial details
- NCT number
- NCT00458679
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-10-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.